Clinical Assessment of Preheated Versus Conventional Bulk Fill Resin Composite

February 14, 2021 updated by: Yasmin Atef Ahmed Ibrahim, Cairo University

Clinical Assessment of Thermo-Viscous Conventional Bulk-fill Resin Composite in Proximal Compound Posterior Restorations : A Randomized Controlled Clinical Trial

A Randomized clinical trial to evaluate the clinical assessment of thermo-viscous versus conventional bulk fill resin composite in proximal compound posterior teeth.The null hypothesis is that there is no difference between thermo-viscous and conventional bulk fill resin composite.

Study Overview

Detailed Description

Despite the improvements in resin composite materials some drawbacks still compromise the longevity of resin composite the most frequent reported limitations are related to polymerization shrinkage , to overcome these problem attempts have been made to improve the mechanical properties , the high viscosity and material stickiness as well as adaptation of the material to the walls was difficult and unpredictable .

Preheating is a method that decreases resin composite viscosity results in better adaptation and wettability of the prepared cavity walls reducing the microleakage.

A new approach based on therm-viscous technology Viscalor bulk (VOCO, Cuxhaven ) a high Viscous composite material at room and body temperature by heating to 68 C converted to flowable consistency.

Preheating composite regarding the lab research have significant clinical advantages as better adaptation reduced leakage and increase of mechanical properties .

Follow up Period will be 1 year , Evaluation will be done at baseline , after 6 months and 12 months .

Study Type

Interventional

Enrollment (Anticipated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Mokattam
      • Cairo, Mokattam, Egypt, 11865
        • Yasmin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 59 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aging more than 18 years .
  • Patients with a high level of oral hygiene.
  • Patients having at least 12 posterior teeth in occlusion.
  • Patients with good likelihood of recall availability.

Tooth Inclusion :

  • Permanent premolars and molars.
  • Moderate to deep compound class II cavities.
  • well formed fully erupted .
  • Vital with positive reaction to cold and hot stimulus.

Exclusion Criteria:

  • Participants with general systematic illness.
  • Pregnant or lactating females.
  • Concomitant participation in another research study.
  • Inability to comply with study procedures.
  • Heavy Bruxism habits.
  • Patients receiving Orthodontic treatment.
  • last experience with allergic reactions against any component of used materials .

Tooth exclusion :

  • Non vital teeth.
  • Secondary carious lesions.
  • Teeth with clinical symptoms of pulpitis such as spontaneous pain or sensitivity to pressure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Thermo-Viscous preheated bulk fill resin composite
Viscalor Despenser (Preheating dispenser for composite Viscalor Bulk Caps)
Viscalor Despenser (Preheating dispenser for composite Viscalor Bulk Caps)
Placebo Comparator: Conventional Bulk Fill resin Composite
GrandioSo X-tra (Voco,Cuxhaven
Nanohybrid Bulk Resin Composite

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marginal Integrity
Time Frame: 1 year
Modified US Public Health Service Criteria (USPHS)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Evaluation of restoration ( Marginal discoloration,secondary caries and Postoperative Sensitivity )
Time Frame: 1 year
Modified US Public Health Service Criteria (USPHS)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olfat Hasanen, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2020

Primary Completion (Anticipated)

May 1, 2021

Study Completion (Anticipated)

June 1, 2021

Study Registration Dates

First Submitted

November 3, 2019

First Submitted That Met QC Criteria

November 3, 2019

First Posted (Actual)

November 5, 2019

Study Record Updates

Last Update Posted (Actual)

February 16, 2021

Last Update Submitted That Met QC Criteria

February 14, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PHD-CU-2019-10-29

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clinical Significance of Thermo-Viscous Composite

Clinical Trials on Viscalor Bulk (VOCO,Cuxhaven)

Subscribe